Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 121 AL 135

Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An Update

Pandey K, Srivastava P, Pandey SK, Johari S, Bhatnagar P, Sonane M, Mishra A.

Curr Mol Med. 2025;25(2):146-166. doi: 10.2174/0115665240334785240913071442.

Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer's disease

Kushwaha N, Panjwani D, Patel S, Ahlawat P, Yadav MR, Patel AS.

J Drug Target. 2025 Feb;33(2):185-205. doi: 10.1080/1061186X.2024.2417012. Epub 2024 Oct 21.

Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease

Inamdar A, Gurupadayya B, Halagali P, Nandakumar S, Pathak R, Singh H, Sharma H.

Curr Pharm Des. 2025;31(8):598-618. doi: 10.2174/0113816128344571241018154506.

Disease-modifying therapies for Alzheimer's disease: Clinical trial progress and opportunity

Zhang Y, Chen J, Li Y, Jiao B, Luo S.

Ageing Res Rev. 2025 Jan;103:102595. doi: 10.1016/j.arr.2024.102595. Epub 2024 Nov 22.

Recent Studies on Heterocyclic Cholinesterase Inhibitors Against Alzheimer's Disease

Tok F.

Chem Biodivers. 2025 Apr;22(4):e202402837. doi: 10.1002/cbdv.202402837. Epub 2024 Dec 3.

The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia

Mohammad Hosseini A, Khaleghzadeh-Ahangar H, Rahimi A.

Neuroscience. 2025 Jan 9;564:271-280. doi: 10.1016/j.neuroscience.2024.11.062. Epub 2024 Nov 26.

Shedding light on microglial dysregulation in Alzheimer's disease: exploring molecular mechanisms and therapeutic avenues

Bhardwaj V, Kumari S, Dhapola R, Sharma P, Beura SK, Singh SK, Vellingiri B, HariKrishnaReddy D.

Inflammopharmacology. 2025 Feb;33(2):679-702. doi: 10.1007/s10787-024-01598-6. Epub 2024 Nov 28.

Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure-activity relationship

Gaur A, Singh YP, Sharma R, Bainsal N.

Arch Pharm (Weinheim). 2025 Jan;358(1):e2400742. doi: 10.1002/ardp.202400742.

Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease

Khan SA, Qamar Z, Rohilla A, Singh PP, Parvez S, Baboota S, Ali J.

Curr Pharm Des. 2025;31(18):1444-1460. doi: 10.2174/0113816128348877241202053633.

Design, current states, and challenges of nanomaterials in anti-neuroinflammation: A perspective on Alzheimer's disease

Hong X, Chen T, Liu Y, Li J, Huang D, Ye K, Liao W, Wang Y, Liu M, Luan P.

Ageing Res Rev. 2025 Mar;105:102669. doi: 10.1016/j.arr.2025.102669. Epub 2025 Jan 27.

Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies

Wang S, Liao Z, Zhang Q, Han X, Liu C, Wang J.

Front Immunol. 2025 Jan 14;15:1484373. doi: 10.3389/fimmu.2024.1484373. eCollection 2024.

Uncovering the intricacies of IGF-1 in Alzheimer's disease: new insights from regulation to therapeutic targeting

Kaur N, Aran KR.

Inflammopharmacology. 2025 Mar;33(3):1311-1330. doi: 10.1007/s10787-025-01641-0. Epub 2025 Jan 30.

Melatonin Overexpression in the Management of Alzheimer's Disease: Therapeutic Exploration

Gupta B, Malviya R, Sundram S, Sridhar SB, Singh DP.

Curr Top Med Chem. 2025;25(15):1783-1794. doi: 10.2174/0115680266327614241121050448.

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, Calon F, Camicioli R, Campbell B, Collins DL, Dadar M, DeMarco ML, Ducharme S, Duchesne S, Einstein G, Fisk JD, Gawryluk JR, Grossman L, Ismail Z, Itzhak I, Joshi M, Harrison A, Kröger E, Kumar S, Laforce R, Lanctot KL, Lau M, Lee L, Masellis M, Massoud F, Mitchell SB, Montero-Odasso M, Myers Barnett K, Nygaard HB, Pasternak SH, Peters J, Rajah MN, Robillard JM, Rockwood K, Rosa-Neto P, Seitz DP, Soucy JP, Trenaman SC, Wellington CL, Zadem A, Chertkow H; Canadian Consortium on Neurodegeneration in Aging Investigators.

J Prev Alzheimers Dis. 2025 Mar;12(3):100068. doi: 10.1016/j.tjpad.2025.100068. Epub 2025 Jan 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias